Cromos Pharma

In the March edition of Cromos Pharma's Newsletter, we bring you the latest breakthroughs and key developments shaping the future of clinical research and healthcare: – FDA Approves a Non-Opioid Pain Treatment – Journavx (suzetrigine) offers a new alternative for managing acute pain. – World Cancer Day 2025: Advancing Oncology Through Clinical Trials – Exploring the impact of nearly 29,000 ongoing studies worldwide. – SCOPE 2025: Key Takeaways – Nicole Brenna shares insights from this year’s Summit for Clinical Operations Executives. And much more! Dive into the full newsletter here: https://lnkd.in/dfXQ2vAP #ClinicalTrials #CromosPharma #Newsletter #HealthcareUpdates

We are pleased to announce that Cromos Pharma’s CEO, Vlad Bogin, MD, FACP will be attending the 11th Annual Immuno-Oncology 360° (IO360°) Summit, taking place March 24-26, 2025, in Boston, MA. As a sponsor of this key industry event, the Cromos Pharma team is committed to supporting innovation and collaboration in immuno-oncology research. The summit will bring together top experts to discuss the latest advancements in clinical trials, translational science, and oncology drug development. Let’s connect at IO360°! If you're attending and would like to discuss your clinical research plans, we’d love to meet you.?To schedule a meeting, please email [email protected] #IO360 #ImmunoOncology #ClinicalTrials #CRO #CromosPharma

On February 27, the second annual Texas BioLife Summits brought together industry leaders to discuss key challenges and innovations in drug development. As part of the event, Vlad Bogin, MD, FACP, participated in a dynamic and thought-provoking panel on clinical trials moderated by Christopher Sauls (Mix Talent). He was joined by Jen Watts (Opthea), Adina Pelusio (KaliVir Immunotherapeutics), Eddie Darton, MD, JD (Sarepta Therapeutics), and Chris Postiglione, MSN, MPH, RN, NREMT-P (Valneva). The discussion explored the critical role of clinical trials in a company’s long-term success, covering AI-driven innovation, optimizing revenue streams during the translational phase, and navigating the complexities of global trial execution. The exchange of ideas was both stimulating and productive, highlighting the importance of strategic collaboration in advancing clinical research. We look forward to continuing these important discussions and driving innovation in the field.? #CromosPharma #ClinicalTrials #Innovation #TexasBioLifeSummit

Over 440 million people worldwide live with rare diseases—each breakthrough brings hope. But how can sponsors navigate complex regulations to accelerate life-changing treatments? As Rare Disease Day 2025 approaches, we explore key regulatory pathways in the US & Europe that help fast-track drug approvals, optimize timelines, and reduce costs. From Orphan Drug Designation to the FDA’s START Program, PRIME, and Accelerated Approval, discover how sponsors can leverage strategic regulatory support to bring therapies to patients faster:https://lnkd.in/e2Nmgjfc #RareDiseaseDay #OrphanDrugs #DrugDevelopment #ClinicalTrials?#CromosPharma

Bulgaria is quickly becoming a key hub for clinical research in Europe, thanks to its strong regulatory framework, skilled professionals, and cost-effective environment. With a growing number of clinical trials and streamlined approval processes, the country offers significant advantages for sponsors and CROs. Read more to discover key insights about Bulgaria’s clinical research potential: https://lnkd.in/gt7Qqfda #ClinicalResearch #CRO #ClinicalTrials #Bulgaria #CromosPharma

We are pleased to announce that Cromos Pharma’s CEO, Vlad Bogin, MD, FACP, is participating in the Texas BioLife Summits 2025, which is set to take place on February 27, 2025, in Dallas, TX. Dr. Bogin will speak on the "Clinical Trial Development" panel, joining a group of industry experts to discuss the key challenges and best practices in running successful clinical trials. The session will cover trial design strategies, protocol development, and vendor and site selection. He looks forward to sharing insights on trial efficiency and addressing common challenges in the development process. Take this opportunity to schedule a meeting with Dr. Bogin during the event. This is a great chance to discuss your upcoming clinical research plans and learn about the benefits of partnering with Cromos Pharma. To arrange a meeting, please email [email protected] #Texas #BioLife #Summit #ClinicalTrials #CRO #CromosPharma

Cromos Pharma is currently seeking a Senior Clinical Research Associate (CRA) to join our team. Location: Türkiye For additional details about this exciting opportunity, please visit our website: https://lnkd.in/dpPbHf3Z If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to [email protected] #hiring #cromospharma #clinicaltrials #Türkiye #CRA

Happy Valentine’s Day! ?? Today, let's celebrate love in all its forms—kindness, connection, and support. May your day be filled with warmth, joy, and meaningful moments. Wishing you happiness and love! #HappyValentinesDay #ClinicalTrials #CRO #CromosPharma

With the conclusion of the 16th Annual Summit for Clinical Operations Executives (SCOPE) held from February 3-6, 2025, in Orlando, industry experts shared key insights into the future of clinical research and development. This year’s discussions centered on artificial intelligence, decentralized clinical trials (DCTs), localization, and strategies for improving efficiency and diversity in clinical trials. Among those gaining firsthand insights into these industry trends was Nicole Brenna, US Business Development Director at Cromos Pharma, who attended SCOPE 2025 and compiled the key takeaways presented in this report. To learn more, read here: https://lnkd.in/et3vnBD4 #ClinicalTrials #ClinicalResearch #SCOPE2025 #CromosPharma

In the February edition of Cromos Pharma's Newsletter, we explore some of the most transformative advancements in clinical research and healthcare: – Reflections from JPM 2025 – CEO Vlad Bogin, MD, FACP shares key takeaways from the JP Morgan Healthcare Conference. – FDA’s AI Guidance – New draft guidelines aim to regulate AI-driven medical devices with a focus on safety and transparency. – Oncology Trial Endpoints – A must-watch video on selecting the right endpoints for successful oncology trials. And much more! Dive into the full newsletter here: https://lnkd.in/eFtA8TPh #ClinicalTrials #CromosPharma #Newsletter #HealthcareUpdates